6 High Yield Pharmaceutical Companies: Do they Justify the Risk?
Chuck Carnevale submits:Introduction Today Investors are keenly focused on income while simultaneously very risk averse. This current behavior brings with it a level of frustration. The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows. On the other hand, dividend yields on many blue-chip stocks are close to double what investors would normally find with this asset class. Complete Story »
- Original article
- Login or register to post comments

